Wire Stories

Laurentian Bank Financial Group reports second quarter 2021 results

The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended April�30,…

5 years ago

Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Osimertinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Osimertinib is a small…

5 years ago

BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (�SINOVAC� or the �Company�) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced…

5 years ago

Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Osimertinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Osimertinib is a small…

5 years ago

Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise

HYDERABAD, India--(BUSINESS WIRE)--#Aragen--Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization,…

5 years ago

Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise

HYDERABAD, India--(BUSINESS WIRE)--#Aragen--Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization,…

5 years ago

BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (�SINOVAC� or the �Company�) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced…

5 years ago

Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets

Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN,…

5 years ago

Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets

Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN,…

5 years ago

Employers must better understand their people to improve staff retention

Employers should use staff assessments to make better-informed people decisions and improve employee retention TRUMBULL, Conn.--(BUSINESS WIRE)--#HR--Staff retention has become…

5 years ago